The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer

被引:75
作者
Pieterse, Q. D.
Kenter, G. G.
Gaarenstroom, K. N.
Peters, A. A. W.
Willems, S. M.
Fleuren, G. J.
Trimbos, J. B. M. Z.
机构
[1] Leiden Univ, Med Ctr, Dept Gynaecol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
来源
EJSO | 2007年 / 33卷 / 02期
关键词
cervical carcinoma; lymphadenectomy; quality control; survival; radical hysterectomy;
D O I
10.1016/j.ejso.2006.09.037
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To determine if the number of removed lymph nodes in radical hysterectomy with lymphadenectomy (RHL) influences survival of patients with early stage cervical cancer and to analyze the relation of different factors like patient age, tumour size and infiltration depth with the number of nodes examined in node-negative early stage cervical cancer patients. Methods: Of consecutive patients, who underwent RHL between January 1984 and April 2005, 331 had negative nodes (group A) without adjuvant therapy and 136 had positive nodes (group B). The Kaplan-Meier method and Cox regression model were used to detect statistical significance. Factors associated with excision of nodes were confirmed with linear regression models. Results: The median number of removed nodes was 19 and 18 for group A and group B, respectively. There was no significant relationship between the number of removed nodes and the cancer specific survival (CSS) or disease free survival (DSF) for patients of group A (p = 0.625 and p = 0.877, respectively). The number of removed nodes in group B was not significantly associated with the CSS (p = 0.084) but it was for the DSF (p = 0.014). Factors like patient age, tumour size and infiltration depth were not associated with the number of nodes. Conclusions: No relation was found between the number of negative nodes examined after RHL for the treatment of early stage cervical cancer and CSS or DFS. However, a higher amount of removed lymph nodes leaded to a better DFS for patients with positive nodes. It is suggested that patients with positive nodes benefit from a complete pelvic lymphadenectomy and a sufficient yield of removed nodes. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:216 / 221
页数:6
相关论文
共 40 条
  • [1] BALTZER J, 1984, GEBURTSH FRAUENHEILK, V44, P279, DOI 10.1055/s-2008-1036658
  • [2] Pelvic and aortic lymphadenectomy
    Benedetti-Panici, P
    Maneschi, F
    Cutillo, G
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2001, 81 (04) : 841 - +
  • [3] Lymphatic spread of cervical cancer: An anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy
    BenedettiPanici, P
    Maneschi, F
    Scambia, G
    Greggi, S
    Cutillo, G
    DAndrea, G
    Rabitti, C
    Coronetta, F
    Capelli, A
    Mancuso, S
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 62 (01) : 19 - 24
  • [4] PROGNOSTIC FACTORS AND OPERATIVE TREATMENT OF STAGE-IB TO STAGE-IIB CERVICAL-CANCER
    BURGHARDT, E
    PICKEL, H
    HAAS, J
    LAHOUSEN, M
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (04) : 988 - 996
  • [5] VALUE OF AXILLARY DISSECTION IN ADDITION TO LUMPECTOMY AND RADIOTHERAPY IN EARLY BREAST-CANCER
    CABANES, PA
    SALMON, RJ
    VILCOQ, JR
    DURAND, JC
    FOURQUET, A
    GAUTIER, C
    ASSELAIN, B
    [J]. LANCET, 1992, 339 (8804) : 1245 - 1248
  • [6] Chan AD, 2000, J AM COLL SURGEONS, V191, P16, DOI 10.1016/S1072-7515(00)00313-6
  • [7] Cosin JA, 1998, CANCER, V82, P2241, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2241::AID-CNCR20>3.0.CO
  • [8] 2-T
  • [9] Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer
    Cragun, JM
    Havrilesky, LJ
    Calingaert, B
    Synan, I
    Secord, AA
    Soper, JT
    Clarke-Pearson, DL
    Berchuck, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3668 - 3675
  • [10] Lymphadenectomy in apparent early-stage endometrial carcinoma: Do numbers count?
    Creutzberg, CL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3653 - 3655